{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T18:49:40Z","timestamp":1767898180347,"version":"3.49.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.molimm.2025.12.009","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:38:43Z","timestamp":1766086723000},"page":"181-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Isoimperatorin inhibits cell proliferation and induces apoptosis via regulating PI3K\/AKT pathway in acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"189","author":[{"given":"Jing","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2025.12.009_bib1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semcancer.2019.07.009","article-title":"PI3K\/Akt\/mTOR inhibitors in cancer: at the bench and bedside","volume":"59","author":"Alzahrani","year":"2019","journal-title":"Semin Cancer Biol."},{"issue":"6","key":"10.1016\/j.molimm.2025.12.009_bib2","doi-asserted-by":"crossref","first-page":"70580","DOI":"10.1016\/S1470-2045(12)70580-6","article-title":"Relapsed childhood acute lymphoblastic leukaemia","volume":"14","author":"Bhojwani","year":"2013","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.molimm.2025.12.009_bib3","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a034819","article-title":"Epidemiology and etiology of leukemia and lymphoma","volume":"10","author":"Bispo","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med"},{"issue":"6","key":"10.1016\/j.molimm.2025.12.009_bib4","first-page":"1713","article-title":"CASZ1 upregulates PI3K-AKT-mTOR signaling and promotes T-cell acute lymphoblastic leukemia","volume":"109","author":"Cardoso","year":"2024","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.molimm.2025.12.009_bib5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.molcel.2019.09.030","article-title":"Mechanisms controlling PD-L1 expression in cancer","volume":"76","author":"Cha","year":"2019","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.molimm.2025.12.009_bib6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13045-020-00853-x","article-title":"Expression patterns of immune checkpoints in acute myeloid leukemia","volume":"13","author":"Chen","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"112196","key":"10.1016\/j.molimm.2025.12.009_bib7","first-page":"17","article-title":"GSG2 promotes progression of human endometrial cancer by regulating PD-1\/PD-L1 expression via PI3K-AKT pathway","volume":"134","author":"Chen","year":"2024","journal-title":"Int Immunopharmacol."},{"issue":"1","key":"10.1016\/j.molimm.2025.12.009_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"issue":"23","key":"10.1016\/j.molimm.2025.12.009_bib9","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1158\/0008-5472.CAN-16-0258","article-title":"Tumor-intrinsic PD-L1 signals regulate cell growth, pathogenesis, and autophagy in ovarian cancer and melanoma","volume":"76","author":"Clark","year":"2016","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.molimm.2025.12.009_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17050779","article-title":"Antibody-based and other novel agents in adult B-cell acute lymphoblastic leukemia","volume":"17","author":"Csizmar","year":"2025","journal-title":"Cancers"},{"issue":"173124","key":"10.1016\/j.molimm.2025.12.009_bib11","first-page":"24","article-title":"Imperatorin: a review of its pharmacology, toxicity and pharmacokinetics","volume":"879","author":"Deng","year":"2020","journal-title":"Eur. J. Pharm."},{"issue":"11","key":"10.1016\/j.molimm.2025.12.009_bib12","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/s41375-023-02020-w","article-title":"FBXO21 mediated degradation of p85\u03b1 regulates proliferation and survival of acute myeloid leukemia","volume":"37","author":"Dobish","year":"2023","journal-title":"Leukemia"},{"issue":"386","key":"10.1016\/j.molimm.2025.12.009_bib13","article-title":"Tumor-intrinsic PD-L1 signaling in cancer initiation, development and treatment: beyond immune evasion","volume":"8","author":"Dong","year":"2018","journal-title":"Front Oncol."},{"issue":"26","key":"10.1016\/j.molimm.2025.12.009_bib14","first-page":"018","article-title":"The intracellular signalosome of PD-L1 in cancer cells","volume":"3","author":"Escors","year":"2018","journal-title":"Signal Transduct. Target Ther."},{"issue":"6","key":"10.1016\/j.molimm.2025.12.009_bib15","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1002\/jcp.29429","article-title":"Targeting Wnt\/\u03b2-catenin and PI3K\/Akt\/mTOR pathways in T-cell acute lymphoblastic leukemia","volume":"235","author":"Evangelisti","year":"2020","journal-title":"J. Cell Physiol."},{"issue":"9","key":"10.1016\/j.molimm.2025.12.009_bib16","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/ni0901-870","article-title":"Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells","volume":"2","author":"Fang","year":"2001","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.molimm.2025.12.009_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140837","article-title":"MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation","volume":"131","author":"Fang","year":"2021","journal-title":"J. Clin. Invest"},{"issue":"9","key":"10.1016\/j.molimm.2025.12.009_bib18","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/10837450.2016.1257023","article-title":"A new polymorph of isoimperatorin","volume":"23","author":"Fu","year":"2018","journal-title":"Pharm. Dev. Technol."},{"issue":"6","key":"10.1016\/j.molimm.2025.12.009_bib19","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/ped.12837","article-title":"Childhood relapsed acute lymphoblastic leukemia: biology and recent treatment progress","volume":"57","author":"Goto","year":"2015","journal-title":"Pedia Int"},{"issue":"5","key":"10.1016\/j.molimm.2025.12.009_bib20","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/sj.leu.2404160","article-title":"Endogenous TNFalpha mediates cell survival and chemotherapy resistance by activating the PI3K\/Akt pathway in acute lymphoblastic leukemia cells","volume":"20","author":"Gu","year":"2006","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.molimm.2025.12.009_bib21","doi-asserted-by":"crossref","first-page":"019","DOI":"10.1038\/s41598-019-48445-1","article-title":"An emerging trend of rapid increase of leukemia but not all cancers in the aging population in the United States","volume":"9","author":"Hao","year":"2019","journal-title":"Sci. Rep."},{"issue":"102861","key":"10.1016\/j.molimm.2025.12.009_bib22","first-page":"19","article-title":"PI3K\/AKT\/mTOR inhibitors for hormone receptor-positive advanced breast cancer","volume":"132","author":"Hao","year":"2025","journal-title":"Cancer Treat. Rev."},{"issue":"3","key":"10.1016\/j.molimm.2025.12.009_bib23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cpt.2024.09.006","article-title":"Claudin-9 (CLDN9) promotes gastric cancer progression by enhancing the glycolysis pathway and facilitating PD-L1 lactylation to suppress CD8(+) T cell anti-tumor immunity","volume":"3","author":"Hu","year":"2024","journal-title":"Cancer Pathog. Ther."},{"issue":"5","key":"10.1016\/j.molimm.2025.12.009_bib24","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20194070","article-title":"LINC00221 suppresses the malignancy of children acute lymphoblastic leukemia","volume":"40","author":"Huang","year":"2020","journal-title":"Biosci. Rep."},{"issue":"16","key":"10.1016\/j.molimm.2025.12.009_bib25","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1182\/blood.2019004043","article-title":"How I treat relapsed acute lymphoblastic leukemia in the pediatric population","volume":"136","author":"Hunger","year":"2020","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.molimm.2025.12.009_bib26","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/ajh.27708","article-title":"Adult acute lymphoblastic leukemia: 2025 update on diagnosis, therapy, and monitoring","volume":"100","author":"Kantarjian","year":"2025","journal-title":"Am. J. Hematol."},{"issue":"110433","key":"10.1016\/j.molimm.2025.12.009_bib27","first-page":"4","article-title":"Isoimperatorin down-regulates epithelial mesenchymal transition through modulating NF-\u03baB signaling and CXCR4 expression in colorectal and hepatocellular carcinoma cells","volume":"99","author":"Kim","year":"2022","journal-title":"Cell Signal"},{"issue":"3","key":"10.1016\/j.molimm.2025.12.009_bib28","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ptr.2043","article-title":"Antiproliferative effect of furanocoumarins from the root of Angelica dahurica on cultured human tumor cell lines","volume":"21","author":"Kim","year":"2007","journal-title":"Phytother. Res"},{"issue":"8","key":"10.1016\/j.molimm.2025.12.009_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25084248","article-title":"Apoptotic effect of isoimpertorin via inhibition of c-Myc and SIRT1 signaling axis","volume":"25","author":"Ko","year":"2024","journal-title":"Int J. Mol. Sci."},{"issue":"111","key":"10.1016\/j.molimm.2025.12.009_bib30","first-page":"015","article-title":"Increase of PD-L1 expressing B-precursor ALL cells in a patient resistant to the CD19\/CD3-bispecific T cell engager antibody blinatumomab","volume":"8","author":"K\u00f6hnke","year":"2015","journal-title":"J. Hematol. Oncol."},{"issue":"10","key":"10.1016\/j.molimm.2025.12.009_bib31","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1136\/jitc-2022-006619","article-title":"PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunity","volume":"11","author":"Koller","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.molimm.2025.12.009_bib32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/cpr.13773","article-title":"The apoptotic and anti-proliferative effects of Neosetophomone B in T-cell acute lymphoblastic leukaemia via PI3K\/AKT\/mTOR pathway inhibition","volume":"58","author":"Kuttikrishnan","year":"2025","journal-title":"Cell Prolif."},{"issue":"2","key":"10.1016\/j.molimm.2025.12.009_bib33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1158\/0008-5472.CAN-14-3362","article-title":"Control of PD-L1 expression by oncogenic activation of the AKT-mTOR pathway in non-small cell lung cancer","volume":"76","author":"Lastwika","year":"2016","journal-title":"Cancer Res"},{"issue":"110425","key":"10.1016\/j.molimm.2025.12.009_bib34","first-page":"20","article-title":"Inhibition of acute leukemia with attenuated Salmonella typhimurium strain VNP20009","volume":"129","author":"Li","year":"2020","journal-title":"Biomed. Pharm."},{"issue":"10","key":"10.1016\/j.molimm.2025.12.009_bib35","first-page":"1286246","article-title":"Hematopoietic stem cell transplantation: a bioethical lens","volume":"27","author":"Liso","year":"2017","journal-title":"Stem Cells Int."},{"issue":"1","key":"10.1016\/j.molimm.2025.12.009_bib36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/187152012798764697","article-title":"Natural products: promising resources for cancer drug discovery","volume":"12","author":"Mondal","year":"2012","journal-title":"Anticancer Agents Med. Chem."},{"issue":"10","key":"10.1016\/j.molimm.2025.12.009_bib37","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/s41409-025-02676-1","article-title":"Outcomes of hematopoietic stem cell transplantation in pediatric acute lymphoblastic leukemia: a multicenter Brazilian cohort study","volume":"60","author":"Morales","year":"2025","journal-title":"Bone Marrow Transpl."},{"issue":"4","key":"10.1016\/j.molimm.2025.12.009_bib38","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/leu.2013.226","article-title":"Targeting the PI3K\/Akt\/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential","volume":"28","author":"Neri","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.molimm.2025.12.009_bib39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.semcancer.2017.04.015","article-title":"PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux","volume":"48","author":"O'Donnell","year":"2018","journal-title":"Semin Cancer Biol."},{"issue":"4","key":"10.1016\/j.molimm.2025.12.009_bib40","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/01.mph.0000161271.68054.b9","article-title":"Electrolyte abnormalities at diagnosis of acute lymphocytic leukemia may be a clue for renal damage in long-term period","volume":"27","author":"Olgar","year":"2005","journal-title":"J. Pedia Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.molimm.2025.12.009_bib41","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.molimm.2025.12.009_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20020412","article-title":"Targeting PI3K Signaling in Acute Lymphoblastic Leukemia","volume":"20","author":"Sanchez","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"108260","key":"10.1016\/j.molimm.2025.12.009_bib43","first-page":"11","article-title":"How CLSPN could demystify its prognostic value and potential molecular mechanism for hepatocellular carcinoma: a crosstalk study","volume":"172","author":"Shi","year":"2024","journal-title":"Comput. Biol. Med"},{"issue":"8","key":"10.1016\/j.molimm.2025.12.009_bib44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1172\/JCI186035","article-title":"LIN28B-mediated PI3K\/AKT pathway activation promotes metastasis in colorectal cancer models","volume":"135","author":"Shin","year":"2025","journal-title":"J. Clin. Invest"},{"issue":"4","key":"10.1016\/j.molimm.2025.12.009_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/cells14040269","article-title":"Hedgehog and PI3K\/Akt\/mTOR signaling pathways involvement in leukemic malignancies: crosstalk and role in cell death","volume":"14","author":"Sicurella","year":"2025","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.molimm.2025.12.009_bib46","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"11","key":"10.1016\/j.molimm.2025.12.009_bib47","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1172\/JCI34616","article-title":"PTEN posttranslational inactivation and hyperactivation of the PI3K\/Akt pathway sustain primary T cell leukemia viability","volume":"118","author":"Silva","year":"2008","journal-title":"J. Clin. Invest"},{"issue":"4","key":"10.1016\/j.molimm.2025.12.009_bib48","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/1043454209340315","article-title":"Chemotherapy-related side effects in childhood acute lymphoblastic leukemia in Indonesia: parental perceptions","volume":"26","author":"Sitaresmi","year":"2009","journal-title":"J. Pedia Oncol. Nurs."},{"issue":"48","key":"10.1016\/j.molimm.2025.12.009_bib49","first-page":"015","article-title":"Apoptosis, autophagy, necroptosis, and cancer metastasis","volume":"14","author":"Su","year":"2015","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.molimm.2025.12.009_bib50","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3892\/ol.2016.5387","article-title":"Isoimperatorin induces apoptosis of the SGC-7901 human gastric cancer cell line via the mitochondria-mediated pathway","volume":"13","author":"Tong","year":"2017","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.molimm.2025.12.009_bib51","first-page":"335","article-title":"Combining nilotinib and PD-L1 blockade reverses CD4+ T-cell dysfunction and prevents relapse in acute B-cell leukemia","volume":"140","author":"Tracy","year":"2022","journal-title":"Blood"},{"issue":"9-10","key":"10.1016\/j.molimm.2025.12.009_bib52","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s10495-024-01982-1","article-title":"FAT10 induces immune suppression by upregulating PD-L1 expression in hepatocellular carcinoma","volume":"29","author":"Wang","year":"2024","journal-title":"Apoptosis"},{"issue":"7","key":"10.1016\/j.molimm.2025.12.009_bib53","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41568-021-00355-z","article-title":"Leukaemia: a model metastatic disease","volume":"21","author":"Whiteley","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.molimm.2025.12.009_bib54","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jgr.2019.07.003","article-title":"20(S)-Ginsenoside Rh2 displays efficacy against T-cell acute lymphoblastic leukemia through the PI3K\/Akt\/mTOR signal pathway","volume":"44","author":"Xia","year":"2020","journal-title":"J. Ginseng Res"},{"issue":"2","key":"10.1016\/j.molimm.2025.12.009_bib55","doi-asserted-by":"crossref","first-page":"019","DOI":"10.1038\/s41419-019-1369-8","article-title":"Downregulation of G2\/mitotic-specific cyclinB1 triggers autophagy via AMPK-ULK1-dependent signal pathway in nasopharyngeal carcinoma cells","volume":"10","author":"Xie","year":"2019","journal-title":"Cell Death Dis."},{"issue":"14","key":"10.1016\/j.molimm.2025.12.009_bib56","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1158\/0008-5472.CAN-18-0040","article-title":"Juxtacrine signaling inhibits antitumor immunity by upregulating PD-L1 expression","volume":"78","author":"Yang","year":"2018","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.molimm.2025.12.009_bib57","first-page":"7993","article-title":"Effects of isoimperatorin on proliferation and apoptosis of human gastric carcinoma cells","volume":"15","author":"Yang","year":"2018","journal-title":"Oncol. Lett."},{"issue":"22","key":"10.1016\/j.molimm.2025.12.009_bib58","first-page":"22869","article-title":"Global burden and trend of acute lymphoblastic leukemia from 1990 to 2017","volume":"12","author":"Yi","year":"2020","journal-title":"Aging"},{"issue":"11","key":"10.1016\/j.molimm.2025.12.009_bib59","doi-asserted-by":"crossref","first-page":"021","DOI":"10.1038\/s41419-021-04293-4","article-title":"Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4\/MyD88\/AKT\/NF-\u03baB pathway in pancreatic cancer","volume":"12","author":"Yin","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.molimm.2025.12.009_bib60","doi-asserted-by":"crossref","first-page":"023","DOI":"10.1038\/s41408-023-00853-3","article-title":"Global burden of hematologic malignancies and evolution patterns over the past 30 years","volume":"13","author":"Zhang","year":"2023","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.molimm.2025.12.009_bib61","doi-asserted-by":"crossref","first-page":"020","DOI":"10.1186\/s12951-020-00738-8","article-title":"Construction of homologous cancer cell membrane camouflage in a nano-drug delivery system for the treatment of lymphoma","volume":"19","author":"Zhao","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.molimm.2025.12.009_bib62","doi-asserted-by":"crossref","first-page":"020","DOI":"10.1038\/s41467-020-20019-0","article-title":"Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment","volume":"11","author":"Zheng","year":"2020","journal-title":"Nat. Commun."},{"issue":"215608","key":"10.1016\/j.molimm.2025.12.009_bib63","first-page":"28","article-title":"DT7 peptide-modified lecithin nanoparticles co-loaded with \u03b3-secretase inhibitor and dexamethasone efficiently inhibit T-cell acute lymphoblastic leukemia and reduce gastrointestinal toxicity","volume":"533","author":"Zhou","year":"2022","journal-title":"Cancer Lett."},{"issue":"Pt 3","key":"10.1016\/j.molimm.2025.12.009_bib64","first-page":"16","article-title":"Chrysotoxine regulates ferroptosis and the PI3K\/AKT\/mTOR pathway to prevent cervical cancer","volume":"338","author":"Zhou","year":"2025","journal-title":"J. Ethnopharmacol."},{"issue":"5-6","key":"10.1016\/j.molimm.2025.12.009_bib65","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s10495-023-01823-7","article-title":"Dissection of pyroptosis-related prognostic signature and CASP6-mediated regulation in pancreatic adenocarcinoma: new sights to clinical decision-making","volume":"28","author":"Zhu","year":"2023","journal-title":"Apoptosis"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589025002937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589025002937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T14:08:02Z","timestamp":1767881282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589025002937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":65,"alternative-id":["S0161589025002937"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2025.12.009","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isoimperatorin inhibits cell proliferation and induces apoptosis via regulating PI3K\/AKT pathway in acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2025.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}